News About Natco Pharma
News About Natco Pharma. Net profit down 31.6% yoy to rs 112.3 crore. 2000 argentia road, plaza 1, suite 200 mississauga, ontario l5n 1p7 tel:
Natco pharma ltd.has informed bse that the meeting of the board of directors of the company is scheduled on 10/11/2022 ,inter alia, to consider and approve the unaudited. Stocks to track in trade for september 26: The company is engaged in the development,.
2000 Argentia Road, Plaza 1, Suite 200 Mississauga, Ontario L5N 1P7 Tel:
Natco pharma ltd., incorporated in the year 1981, is a mid cap company (having a market cap of rs 10403.02 crore) operating in pharmaceuticals sector. Natco pharma ltd.has informed bse that the meeting of the board of directors of the company is scheduled on 10/11/2022 ,inter alia, to consider and approve the unaudited. The company had posted a consolidated net profit of rs 53 crore in the same quarter previous fiscal, natco pharma said.
Stocks To Track In Trade For September 26:
Natco pharma limited's (nse:natcopharm) most bullish insider, senior key executive venkaiah nannapaneni must be pleased with the recent 4.5% gain. What wall street is expecting markets insider automation 1,378d natco pharma is about to announce earnings — here's what wall street expects Natco pharma reports q4 net loss at rs 50.5 crore.
Business | Press Trust Of India | Tuesday August 9, 2016.
Natco has proudly served canadian patients with quality medicines since 2006. Natco is the first company in india to have received its registration approval given by the. Net profit down 31.6% yoy to rs 112.3 crore.
News, Information And Stories For Natco Pharma Limited | Nse India Stock Exchange:
8.00 pm | 12 nov 2022 | business standard. Natco pharma, britannia industries, infibeam avenues, anupam rasayan, harsha engineering stock market essentials for. Natco is set to scale new heights with an array of new products that leverage our trusted global pipeline.
The Company Is Engaged In The Development,.
Natcopharm | nse india stock exchange Icici direct recommended hold rating on natco pharma with a target price of rs 660 in its research report dated november 17, 2022. The suit is expected to impact natco.
Post a Comment for "News About Natco Pharma"